Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Sales | 91,847 | 92,401 | 85,231 | 125,904 | 77,344 |
| Gross Profit | 91,847 | 92,401 | 85,231 | 125,904 | 77,344 |
| Operating Expenses | 7,186 | 7,732 | 5,647 | 5,145 | 6,945 |
| Operating Income | 84,661 | 84,669 | 79,584 | 120,759 | 70,399 |
| Interest Expense | 6,000 | 5,950 | 6,514 | 7,872 | 8,700 |
| Other Income | 3,838 | -1,627 | 1,867 | 428 | 90 |
| Pre-tax Income | 82,499 | 77,092 | 74,937 | 113,315 | 61,789 |
| Income Tax | 29,028 | 27,684 | 26,362 | 39,813 | 21,605 |
| Net Income Continuous | 53,471 | 49,408 | 48,575 | 73,502 | 40,184 |
| Net Income | $53,471 | $49,408 | $48,575 | $73,502 | $40,184 |
| EPS Basic Total Ops | 0.38 | 0.35 | 0.35 | 0.53 | 0.29 |
| EPS Basic Continuous Ops | 0.38 | 0.35 | 0.35 | 0.53 | 0.29 |
| EPS Diluted Total Ops | 0.36 | 0.32 | 0.32 | 0.52 | 0.29 |
| EPS Diluted Continuous Ops | 0.36 | 0.32 | 0.32 | 0.52 | 0.29 |
| EBITDA(a) | $87,962 | $88,011 | $83,088 | $124,600 | $74,365 |